Cargando…

Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children

BACKGROUND: Treatment of clinical Plasmodium falciparum malaria with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) is associated with increased post-treatment gametocyte carriage. The effect of seasonal malaria chemoprevention (SMC) with SP and AQ on gametocyte carriage was assessed in asympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Abdullahi, Prom, Aurelia, Bradley, John, Ndiath, Mamadou, Etoketim, Blessed, Bah, Mamadou, Van Geertruyden, Jean-Pierre, Drakeley, Chris, Bousema, Teun, Achan, Jane, D’Alessandro, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995796/
https://www.ncbi.nlm.nih.gov/pubmed/33771166
http://dx.doi.org/10.1186/s12936-021-03706-1
_version_ 1783669982445436928
author Ahmad, Abdullahi
Prom, Aurelia
Bradley, John
Ndiath, Mamadou
Etoketim, Blessed
Bah, Mamadou
Van Geertruyden, Jean-Pierre
Drakeley, Chris
Bousema, Teun
Achan, Jane
D’Alessandro, Umberto
author_facet Ahmad, Abdullahi
Prom, Aurelia
Bradley, John
Ndiath, Mamadou
Etoketim, Blessed
Bah, Mamadou
Van Geertruyden, Jean-Pierre
Drakeley, Chris
Bousema, Teun
Achan, Jane
D’Alessandro, Umberto
author_sort Ahmad, Abdullahi
collection PubMed
description BACKGROUND: Treatment of clinical Plasmodium falciparum malaria with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) is associated with increased post-treatment gametocyte carriage. The effect of seasonal malaria chemoprevention (SMC) with SP and AQ on gametocyte carriage was assessed in asymptomatic P. falciparum infected children. METHODS: The study was carried out in eastern Gambia. Asymptomatic P. falciparum malaria infected children aged 24–59 months old who were eligible to receive SMC (SMC group) and children 5–8 years that were not eligible to receive SMC (comparison group) were recruited. Gametocytaemia was determined by molecular methods before and after SMC administration. Gametocyte carriage between the groups was compared using the chi-squared test and within-person using conditional logistic regression. RESULTS: During the 2017 and 2018 malaria transmission seasons, 65 and 75 children were recruited in the SMC and comparison groups, respectively. Before SMC administration, gametocyte prevalence was 10.7% (7/65) in the SMC group and 13.3% (10/75) in the comparison group (p = 0.64). At day 13 (IQR 12, 13) after SMC administration, this was 9.4% (5/53) in children who received at least the first dose of SMC treatment and 12.7% (9/71) for those in the comparison group (p = 0.57). Similarly, there was no difference in prevalence of gametocytes between children that adhered to all 3-day doses of SMC treatment 15.6% (5/32) and those in the comparison group (p = 0.68). In the SMC group, within-group gametocyte carriage was similar before and after SMC administration in children that received at least the first dose of SMC treatment (OR 0.6, 95% CI 0.14–2.51; p = 0.48) and in those that adhered to all 3-day doses of SMC treatment (OR 1.0, 95% CI 0.20–4.95; p = 1.0). CONCLUSION: In this study with relative low gametocyte prevalence prior to SMC treatment, no evidence was observed that SMC treatment increased gametocyte carriage in asymptomatic P. falciparum malaria infected children.
format Online
Article
Text
id pubmed-7995796
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79957962021-03-30 Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children Ahmad, Abdullahi Prom, Aurelia Bradley, John Ndiath, Mamadou Etoketim, Blessed Bah, Mamadou Van Geertruyden, Jean-Pierre Drakeley, Chris Bousema, Teun Achan, Jane D’Alessandro, Umberto Malar J Research BACKGROUND: Treatment of clinical Plasmodium falciparum malaria with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) is associated with increased post-treatment gametocyte carriage. The effect of seasonal malaria chemoprevention (SMC) with SP and AQ on gametocyte carriage was assessed in asymptomatic P. falciparum infected children. METHODS: The study was carried out in eastern Gambia. Asymptomatic P. falciparum malaria infected children aged 24–59 months old who were eligible to receive SMC (SMC group) and children 5–8 years that were not eligible to receive SMC (comparison group) were recruited. Gametocytaemia was determined by molecular methods before and after SMC administration. Gametocyte carriage between the groups was compared using the chi-squared test and within-person using conditional logistic regression. RESULTS: During the 2017 and 2018 malaria transmission seasons, 65 and 75 children were recruited in the SMC and comparison groups, respectively. Before SMC administration, gametocyte prevalence was 10.7% (7/65) in the SMC group and 13.3% (10/75) in the comparison group (p = 0.64). At day 13 (IQR 12, 13) after SMC administration, this was 9.4% (5/53) in children who received at least the first dose of SMC treatment and 12.7% (9/71) for those in the comparison group (p = 0.57). Similarly, there was no difference in prevalence of gametocytes between children that adhered to all 3-day doses of SMC treatment 15.6% (5/32) and those in the comparison group (p = 0.68). In the SMC group, within-group gametocyte carriage was similar before and after SMC administration in children that received at least the first dose of SMC treatment (OR 0.6, 95% CI 0.14–2.51; p = 0.48) and in those that adhered to all 3-day doses of SMC treatment (OR 1.0, 95% CI 0.20–4.95; p = 1.0). CONCLUSION: In this study with relative low gametocyte prevalence prior to SMC treatment, no evidence was observed that SMC treatment increased gametocyte carriage in asymptomatic P. falciparum malaria infected children. BioMed Central 2021-03-26 /pmc/articles/PMC7995796/ /pubmed/33771166 http://dx.doi.org/10.1186/s12936-021-03706-1 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ahmad, Abdullahi
Prom, Aurelia
Bradley, John
Ndiath, Mamadou
Etoketim, Blessed
Bah, Mamadou
Van Geertruyden, Jean-Pierre
Drakeley, Chris
Bousema, Teun
Achan, Jane
D’Alessandro, Umberto
Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children
title Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children
title_full Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children
title_fullStr Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children
title_full_unstemmed Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children
title_short Gametocyte carriage after seasonal malaria chemoprevention in Plasmodium falciparum infected asymptomatic children
title_sort gametocyte carriage after seasonal malaria chemoprevention in plasmodium falciparum infected asymptomatic children
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995796/
https://www.ncbi.nlm.nih.gov/pubmed/33771166
http://dx.doi.org/10.1186/s12936-021-03706-1
work_keys_str_mv AT ahmadabdullahi gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT promaurelia gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT bradleyjohn gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT ndiathmamadou gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT etoketimblessed gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT bahmamadou gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT vangeertruydenjeanpierre gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT drakeleychris gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT bousemateun gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT achanjane gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren
AT dalessandroumberto gametocytecarriageafterseasonalmalariachemopreventioninplasmodiumfalciparuminfectedasymptomaticchildren